{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:00:20Z","timestamp":1793678420793,"version":"4.5.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:00:00Z","timestamp":1757203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007059","name":"Palacky University Olomouc","doi-asserted-by":"publisher","award":["LF_2025_002"],"award-info":[{"award-number":["LF_2025_002"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010823","name":"Tore Nilson Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","award":["20200505"],"award-info":[{"award-number":["20200505"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","award":["20200506"],"award-info":[{"award-number":["20200506"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.coi.2025.102663","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:26:48Z","timestamp":1758587208000},"page":"102663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["From genes to granulomas: the genetic blueprint of sarcoidosis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4517-7825","authenticated-orcid":false,"given":"Martin","family":"Petrek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1298-1243","authenticated-orcid":false,"given":"Natalia V","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102663_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2023.06.004","article-title":"Epidemiology of sarcoidosis","volume":"45","author":"Cozier","year":"2024","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.coi.2025.102663_bib2","article-title":"Global burden of pulmonary sarcoidosis from 1990 to 2021: a comprehensive analysis based on the GBD 2021 study","volume":"12","author":"Cao","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2025.102663_bib3","article-title":"Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study","volume":"53","author":"Bechman","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.coi.2025.102663_sbref4","article-title":"Epidemiological disparities in pulmonary sarcoidosis between public and private healthcare sectors in Haute-Garonne department (France)","volume":"88","author":"Divenah","year":"2025","journal-title":"Respir Med Res"},{"key":"10.1016\/j.coi.2025.102663_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00964-2024","article-title":"Familial risk and phenotypic variation of sarcoidosis in the Icelandic population","volume":"11","author":"Arnadottir","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.coi.2025.102663_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.puhe.2024.10.011","article-title":"Prevalence of sarcoidosis in Colombia: an analysis of the Ministry of Health databases","volume":"237","author":"Bautista-Vargas","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.coi.2025.102663_bib7","article-title":"Characteristics and incidence of cardiac events across spectrum of age in cardiac sarcoidosis","volume":"50","author":"Nabeta","year":"2024","journal-title":"Int\u00a0J Cardiol Heart Vasc"},{"key":"10.1016\/j.coi.2025.102663_bib8","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1080\/09273948.2025.2452193","article-title":"Epidemiological characterization of uveitis in Japan: a systematic review","volume":"33","author":"Liba","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.coi.2025.102663_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102483","article-title":"The role of ICDs in patients with sarcoidosis\u00a0\u2014\u00a0a comprehensive review","volume":"49","author":"Mactaggart","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.coi.2025.102663_sbref10","article-title":"Trends and disparities in cardiovascular death in sarcoidosis: a population-based retrospective study in the United States from 1999 to 2020","volume":"13","author":"Tan","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.coi.2025.102663_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/joim.13629","article-title":"Sarcoidosis: epidemiology and clinical insights","volume":"293","author":"Rossides","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.coi.2025.102663_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s00403-024-03726-2","article-title":"Epidemiology of cutaneous sarcoidosis in an electronic health database: a cross-sectional analysis","volume":"317","author":"Gaurav","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.coi.2025.102663_sbref13","article-title":"Inequalities and age-period-cohort effects of global and regional burden for interstitial lung disease and pulmonary sarcoidosis: based on Global Burden of Disease study 2021","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2025.102663_sbref14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/occmed\/kqae016","article-title":"Occupational exposures and sarcoidosis: a rapid review of the evidence","volume":"74","author":"Rezai","year":"2024","journal-title":"Occup Med"},{"key":"10.1016\/j.coi.2025.102663_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/occmed\/kqae137","article-title":"Occupational exposure and sarcoidosis: a case-control study in three countries","volume":"75","author":"Vinnikov","year":"2025","journal-title":"Occup Med"},{"key":"10.1016\/j.coi.2025.102663_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/inthealth\/ihae030","article-title":"Sarcoidosis in first- and second-generation immigrants: a cohort study of all adults 18 years of age and older in Sweden","volume":"17","author":"W\u00e4ndell","year":"2024","journal-title":"Int Health"},{"key":"10.1016\/j.coi.2025.102663_bib17","article-title":"Sarcoidosis shares susceptibility loci with autoimmune disorders and cancers","volume":"64","author":"Patasova","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coi.2025.102663_sbref18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.it.2024.04.013","article-title":"Sarcoidosis immunopathogenesis \u2014 a new concept of maladaptive trained immunity","volume":"45","author":"Robert","year":"2024","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2025.102663_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.it.2025.01.002","article-title":"The 'inflammazone' in chronic inflammatory diseases: psoriasis and sarcoidosis","volume":"46","author":"Saw","year":"2025","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2025.102663_bib20","series-title":"Unravelling the genetic basis of sarcoidosis","first-page":"41","author":"van Moorsel","year":"2022"},{"key":"10.1016\/j.coi.2025.102663_bib21","article-title":"Unraveling genetic mysteries: phenotype-shaping profiles in chronic sarcoidosis","author":"Kullberg","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.coi.2025.102663_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.arbres.2025.04.014","article-title":"Unraveling genetics in sarcoidosis: next steps","volume":"61","author":"Rivera","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.coi.2025.102663_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1132799","article-title":"Sex differences in the genetics of sarcoidosis across European and African ancestry populations","volume":"10","author":"Xiong","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2025.102663_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1061654","article-title":"Functional link between sarcoidosis-associated gene variants and quantitative levels of bronchoalveolar lavage fluid cell types","volume":"10","author":"Abo Al Hayja","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2025.102663_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cei\/uxad052","article-title":"Peripheral blood lymphopenia in sarcoidosis associates with HLA-DRB1 alleles but not with lung immune cells and organ involvement","volume":"213","author":"Darlington","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2025.102663_bib26","article-title":"Elevated serum angiotensin converting enzyme correlates with specific HLA-DRB1 alleles and extrapulmonary manifestations in sarcoidosis","volume":"86","author":"Rossides","year":"2024","journal-title":"Respir Med Res"},{"key":"10.1016\/j.coi.2025.102663_sbref27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46915-1","article-title":"Human leukocyte antigen-DQ risk heterodimeric haplotypes of left ventricular dysfunction in cardiac sarcoidosis: an autoimmune view of its role","volume":"13","author":"Yamamoto","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102663_sbref28","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00441-2024","article-title":"Family history of pulmonary fibrosis impacts prognosis in patients with sarcoidosis","volume":"11","author":"Plant\u00e9-Bordeneuve","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.coi.2025.102663_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101745","article-title":"Is it time to incorporate genomic data in the routine evaluation of cardiac sarcoidosis?","volume":"4","author":"Ezzeddine","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.coi.2025.102663_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148706","article-title":"Association of HLA variants and related SNPs with sarcoidosis and its phenotypes in the Greek patients","volume":"927","author":"Strnad","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.coi.2025.102663_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1094843","article-title":"Association between sarcoidosis and HLA polymorphisms in a Czech population from Central Europe: focus on a relationship with clinical outcome and treatment","volume":"10","author":"Sikorova","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2025.102663_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13199-w","article-title":"HLA class II variants defined by next generation sequencing are associated with sarcoidosis in Korean patients","volume":"12","author":"Sikorov\u00e1","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102663_bib33","article-title":"HLA genes and sarcoidosis across three populations: Greeks, Czechs, and Koreans","volume":"64","author":"Pet\u0159ek","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coi.2025.102663_sbref34","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1218106","article-title":"Genetic and geographic influence on phenotypic variation in European sarcoidosis patients","volume":"10","author":"Freitag-Wolf","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2025.102663_sbref35","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/hmg\/ddad067","article-title":"Genome-wide association study identifies multiple HLA loci for sarcoidosis susceptibility","volume":"32","author":"Liao","year":"2023","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2025.102663_sbref36","article-title":"GWAS identifies genetic loci, lifestyle factors and circulating biomarkers that are risk factors for sarcoidosis","volume":"16","author":"Yuan","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102663_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1164\/rccm.202308-1331LE","article-title":"Genome and transcriptome-wide association study of fibrotic sarcoidosis in European Americans","volume":"209","author":"Liao","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2025.102663_sbref38","article-title":"Deciphering the genetic tapestry: insights into sarcoidosis across diverse populations with the MESARGEN Consortium","volume":"64","author":"Rivera","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.coi.2025.102663_bib39","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/rheumatology\/keae048","article-title":"Joint involvement in sarcoidosis: systematic review and meta-analysis of prevalence, clinical pattern and outcome","volume":"63","author":"Yeung","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102663_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103247","article-title":"The immunopathogenesis of sarcoidosis","volume":"149","author":"Miedema","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102663_bib41","article-title":"Immunological pathways in sarcoidosis and autoimmune rheumatic disorders\u2014similarities and differences in an Italian prospective real-life preliminary study","volume":"11","author":"D'Alessandro","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.coi.2025.102663_bib42","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1164\/rccm.202307-1273OC","article-title":"Aberrant lipid metabolism in macrophages is associated with granuloma formation in sarcoidosis","volume":"209","author":"Lim","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2025.102663_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178711","article-title":"Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases","volume":"134","author":"Sati","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coi.2025.102663_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175264","article-title":"Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis","volume":"134","author":"Weeratunga","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coi.2025.102663_bib45","article-title":"From fibrosis to granuloma: drug induced systemic sarcoidosis-like reaction after rituximab in a patient with primary Sj\u00f6gren's syndrome","volume":"11","author":"Coelho","year":"2024","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.coi.2025.102663_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103481","article-title":"New onset sarcoidosis following biologic treatment in patients with seronegative inflammatory arthritis: a case series and systematic literature review","volume":"23","author":"Donzella","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2025.102663_bib47","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/jvc2.369","article-title":"Paradoxical granulomatous reaction to ustekinumab","volume":"3","author":"Obijiofor","year":"2024","journal-title":"JEADV Clin Pract"},{"key":"10.1016\/j.coi.2025.102663_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107640","article-title":"Sarcoid-like reactions to immune checkpoint inhibitors: incidence, treatment course, and impact on cancer progression and survival","volume":"227","author":"Smith","year":"2024","journal-title":"Respir Med"},{"key":"10.1016\/j.coi.2025.102663_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf017","article-title":"Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors","volume":"30","author":"Nykaza","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.coi.2025.102663_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14072381","article-title":"Fibrotic pulmonary sarcoidosis \u2014 from pathogenesis to management","volume":"14","author":"\u0141y\u017cwa","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.coi.2025.102663_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051250","article-title":"Clinical pharmacology in sarcoidosis: how to use and monitor sarcoidosis medications","volume":"13","author":"Kwon","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.coi.2025.102663_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00408-023-00626-6","article-title":"Multiple correspondence analysis and HLA-associations of organ involvement in a large cohort of African-American and European-American patients with sarcoidosis","volume":"201","author":"Rasmussen","year":"2023","journal-title":"Lung"},{"key":"10.1016\/j.coi.2025.102663_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147577","article-title":"Evaluation of genetic risk, its clinical manifestation and disease management based on 18 susceptibility gene markers among West-Slavonic patients with sarcoidosis","volume":"878","author":"Kishore","year":"2023","journal-title":"Gene"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:41:16Z","timestamp":1775032876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"alternative-id":["S0952791525001396"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102663","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From genes to granulomas: the genetic blueprint of sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102663"}}